BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 3923822)

  • 1. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
    Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
    Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation.
    Rao AK; Koike K; Willis J; Daniel JL; Beckett C; Hassel B; Day HJ; Smith JB; Holmsen H
    Blood; 1984 Oct; 64(4):914-21. PubMed ID: 6089937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects.
    Rao AK; Willis J; Hassell B; Dangelmaier C; Holmsen H; Smith JB
    Am J Hematol; 1984 Aug; 17(2):153-65. PubMed ID: 6431801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of human platelet phospholipids with linoleic acid diminishes thromboxane release.
    Needleman SW; Spector AA; Hoak JC
    Prostaglandins; 1982 Nov; 24(5):607-22. PubMed ID: 6819602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of endotoxin on arachidonic acid release and thromboxane B2 production by human platelets.
    Stuart MJ
    Am J Hematol; 1981 Sep; 11(2):159-64. PubMed ID: 7030066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of arachidonic acid by platelets in nephrotic syndrome.
    Schieppati A; Dodesini P; Benigni A; Massazza M; Mecca G; Remuzzi G; Livio M; de Gaetano G; Rossi EC
    Kidney Int; 1984 Apr; 25(4):671-6. PubMed ID: 6434788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
    Sekiya K; Okuda H
    Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin pretreatment of human platelets impairs thromboxane A2 synthesis from endogenous precursors in the presence of normal cyclooxygenase activity.
    Reimers HJ; Scharf RE; Baker RK
    Blood; 1984 Apr; 63(4):858-65. PubMed ID: 6231068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective acid hydrolase secretion in RUNX1 haplodeficiency: Evidence for a global platelet secretory defect.
    Rao AK; Poncz M
    Haemophilia; 2017 Sep; 23(5):784-792. PubMed ID: 28662545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production.
    Mikhailidis DP; Barradas MA; Dandona P
    Am J Clin Pathol; 1986 Jun; 85(6):754-5. PubMed ID: 3706213
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis.
    Shorr RI; Kao KJ; Pizzo SV; Rauckman EJ; Rosen GM
    Thromb Res; 1985 Apr; 38(1):33-43. PubMed ID: 3923647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase.
    Lagarde M; Byron PA; Vargaftig BB; Dechavanne M
    Br J Haematol; 1978 Feb; 38(2):251-66. PubMed ID: 205238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of preactivated human blood platelets to restore defective thromboxane synthesis despite prolonged incubation in plasma.
    Stockschläder M; Scharf RE
    Thromb Haemost; 1989 Nov; 62(3):1016-22. PubMed ID: 2512674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture.
    Walenga RW; Miller JL; Stuart MJ
    Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
    J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.